PLXND1 and neoplasm: SEMA3C has been observed to function as a potent inhibitor of angiogenesis and lymphangiogenesis, which is likely mediated by the activation of plexin-D1-dependent signal transduction in endothelial cells and lymphatic endothelial cells, resulting in the inhibition of tumor progression 38.